← Leaderboards
Richard Louis Klein
Ralph H Johnson Va Medical Center
$1,025,843
Attributed
$2,051,685
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $440.8K · FY2012–19$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,051,685 · 1
VA$0 · 2
By mechanism
R01$2,051,685 · 1
I01$0 · 2
Top collaborators
- Maria F Lopes-Virella5 shared
Others in their field
Top investigators on “Diabetic Patient”
- Jeffrey P Krischer · University Of South Florida$218,300,502
- John M Lachin · George Washington University$155,894,464
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$149,688,362
- David M Nathan · Massachusetts Institute Of Technology$132,111,078
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Rose A Gubitosi-Klug · Case Western Reserve University$62,712,863
Research focus
Diabetic PatientLow-Density LipoproteinsCell PhysiologyMetabolismVery Low Density LipoproteinPlasmaSphingolipidsCellsHigh Density LipoproteinsDiabetes MellitusLipoproteinsSamplingLipidsCeramidesBloodKidney DiseasesExcretory FunctionMacroalbuminuriaAlbuminuriaDiabetic NephropathyComplications Of Diabetes MellitusGlycemic ControlAlbuminsCohort
Grant awards (11)
The Role of Deoxysphingolipids in Peripheral Neuropathy$0
I01 · FY2019 · VA · contact PI
Role of Sphingolipids in the Development of Diabetic Nephropathy$402,716
R01 · FY2018 · DK
The Role of Deoxysphingolipids in Peripheral Neuropathy$0
I01 · FY2018 · VA · contact PI
Role of Sphingolipids in the Development of Diabetic Nephropathy$402,716
R01 · FY2017 · DK
Role of Sphingolipids in the Development of Diabetic Nephropathy$402,716
R01 · FY2016 · DK
Role of Sphingolipids in the Development of Diabetic Nephropathy$402,716
R01 · FY2015 · DK
Interactions of Lipoproteins and Cells in Diabetes Mellitus$0
I01 · FY2015 · VA · contact PI
Role of Sphingolipids in the Development of Diabetic Nephropathy$440,821
R01 · FY2014 · DK
Interactions of Lipoproteins and Cells in Diabetes Mellitus$0
I01 · FY2014 · VA · contact PI
Interactions of Lipoproteins and Cells in Diabetes Mellitus$0
I01 · FY2013 · VA · contact PI
Interactions of Lipoproteins and Cells in Diabetes Mellitus$0
I01 · FY2012 · VA · contact PI